Cellosaurus LNCaP-PDR2 (CVCL_C0RS)
| Cell line name | LNCaP-PDR2 |
|---|---|
| Synonyms | LNCaP PDR2; LN-PDR2 |
| Accession | CVCL_C0RS |
| Resource Identification Initiative | To cite this cell line use: LNCaP-PDR2 (RRID:CVCL_C0RS) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance). Omics: Proteomics; PTM; Phosphorylation; Quantitative. Omics: Transcriptomics; RNAseq. Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056. |
| Sequence variations |
|
| Disease | Prostate carcinoma (NCIt: C4863) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0395 (LNCaP) |
| Sex of cell | Male |
| Age at sampling | 50Y |
| Category | Cancer cell line |
| Publications | PubMed=29739788; DOI=10.1158/1078-0432.CCR-18-0410; PMCID=PMC6125187 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_C0RS |
| Encyclopedic resources | Wikidata; Q112930020 |
| Gene expression databases | GEO; GSM2650011
GEO; GSM2650012 GEO; GSM2650013 GEO; GSM2650014 GEO; GSM2650015 GEO; GSM2650016 |
| Proteomic databases | PRIDE; PXD006561 |
| Entry history | |
| Entry creation | 23-Jun-2022 |
| Last entry update | 10-Apr-2025 |
| Version number | 7 |